Hi everybody,
Would like to know how are you treating in your hospitals this clinical situation.
Standard will be RT (66-68Gy) no ADT.
There is some evidence about dose escalation (King 2008 ijrobp and Bernard 2010 ijrobp) there is also evidence about ADT (Choo 2009 ijrobp). Most of the ongoing phase III clinical trials (RTOG 0543, RADICALS, JCOG 0401…) are investigating the combination of RT and ADT.
Are you using this combination? Which dose are you administering?
Thanks